Please wait...

Learn

Finding accredited CPD

Respiratory syncytial virus preventives for children in Australia: current landscape and future directions

Description

Globally, respiratory syncytial virus (RSV) is responsible for an estimated 33 million acute lower respiratory tract infections, resulting in 26300 in‐hospital deaths annually in children aged 0 to 60 months. Children under the age of 4 years are disproportionately impacted and represent 50% of cases, with infants under the age of 6 months accounting for most of the RSV‐associated hospitalisations in Australia.

The majority of infants hospitalised with severe RSV infection are otherwise healthy; however, certain risk factors have been identified including: younger age, prematurity, and underlying lung or heart conditions. First Nations children, who are at an increased risk of lung diseases (eg, asthma and bronchiectasis) compared with non‐First Nations children, also experience higher rates of RSV hospitalisation, with 789 per 100 000 affected in individuals under 5 years, nearly double the rate in non‐First Nations children (420 per 100 000).

This MJA Narrative Review shares more.


Details

Authors: Sam T Barnett, Jane Tuckerman, Ian G Barr, Nigel W Crawford and Danielle F Wurzel

Article Type: Narrative Review

CPD Activity Details
Provider
MJA
Domain
Educational Activities
Type
General Learning
Activity
Professional reading
CPD Hours
0h : 30m
Topic
Respiratory System Diseases, Infectious Diseases, Paediatric Medicine
Audience
Medical practitioners
Applicable CAPE Aspects
_
Effective Year

You have to log in to see the content of this module.


Provided by


Accepted by

*Medical Board of Australia’s (MBA)’s revised Registration Standard: Continuing professional development (the Standard)